Clinical Trials Directory

Trials / Unknown

UnknownNCT06207279

Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Peking University Sixth Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study, based on preliminary experimental results, literature review, and expert consultations, developed the Attentional Rating Scale (ARS). The aim was to rapidly assess participants' attention and potential influencing factors. The research focused on the scale's reliability and validity among healthy adults. Additionally, the Attention Network Test (ANT) served as the gold standard for evaluating attention. The study attempted to identify correlations between various dimensions of attention and the three attentional networks.

Detailed description

1. To adiministrate 60 healthy subjects to evaluate internal consistency reliability. 2. To choose 20 cases for ARS retesting 7 days after the first ARS evaluation. 3. To evaluate the split half reliability through the Spearman Brown coefficient. 4. To apply principal component analysis for structural validity analysis. 5. Using the Attention Network Test (ANT) and Toronto Hospital Alertness Test (THE) as gold standards, the Pearson correlation coefficient was used for criterion validity analysis. 6. To administrate 60 patients with MDD, ADHD and insomnia disorder testing the discrimination validity of ARS.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTratingrating scales, test ANT

Timeline

Start date
2023-09-28
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-01-16
Last updated
2024-02-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06207279. Inclusion in this directory is not an endorsement.